20xx年醫(yī)學專題—essen評分與腦卒中(存儲版)
【正文】 推薦，B級證據）。ng)的中國專家共識。nzhǎo)面臨卒中復發(fā)的高危人群,1. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996。2008 BMJ Publishing Group Ltd.,Weimar, C et al. J Neurol Neurosurg Psychiatry 2008。,一年致死性和非致死性卒中（白）以及聯合心血管事件(sh236。,Diener HC, et al. Clopidogrel for the secondary prevention of stroke. Expert Opin Pharmacother, 2005,6(5):755764.,CAPRIE ：缺血性卒中患者(hu224。13391343。,尋找面臨卒中復發(fā)的高危(ɡāo wēi)人群,ESRS : Essen Stroke Risk Score Essen卒中風險(fēngxiǎn)評分量表1,1. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events Lancet 1996。)卒中風險,隨訪(su237。 依據各種抗血小板治療藥物的獲益、相應風險及費用進行個體化治療（II類推薦，C級證據）。f225。d236。 fā)：卒中易損病人,第三頁，共二十六頁。nɡ y224。,一級預防 Framingham SCORE SPAFIII, CHADS2 index (Atrial Fibrillation),二級預防(y249。,已經(yǐ jing)驗證的危險分層工具,Primary Secondary prevention Titel Framingham SPI II ABCD Essen Prediction given 10 years 2 years 7 days 2 years Index event asymptomatic IS
環(huán)評公示相關推薦
鄂ICP備17016276號-1